ResearcherSecond Affiliated Hospital of Zhejiang UniversityNo recent work listed

Jia Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7945-6953; OpenAlex author ID A5066303828. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2015: 1 paper · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 1 paper

Papers 2

Dilemma and Challenge of Immunotherapy for Pancreatic Cancer. Co-author DOI 10.1007/s10620-020-06183-9 ↗
The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells. Co-author DOI 10.1038/srep12230 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianting Cai · 2 shared papers, 2015–2021 · strength 0.33
- Paper Dilemma and Challenge of Immunotherapy for Pancreatic Cancer. DOI 10.1007/s10620-020-06183-9 ↗
- Paper The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells. DOI 10.1038/srep12230 ↗
Litao Jia · 1 shared paper, 2015 · strength 0.05
- Paper The virus-induced protein APOBEC3G inhibits anoikis by activation of Akt kinase in pancreatic cancer cells. DOI 10.1038/srep12230 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.